US stock · Healthcare sector · Pharmaceutical Retailers
Company Logo

Rite Aid Corporation

RADNYSE

6.51

USD
+0.01
(+0.15%)
Market Open
-0.56P/E
-4Forward P/E
-0.03P/E to S&P500
362.130MMarket CAP
- -Div Yield
Upcoming Earnings
29 Sep
Shares Short
8/31/22
8.46M
Short % of Float
17.72%
Short % of Shares Outs.
15.21%
% Held by Insiders
3.88%
% Held by Institutions
61.71%
Beta
1.03
PEG Ratio
1.27
52w. high/low
15.65/4.68
Avg. Daily Volume
2.29M
Return %
Stock
S&P 500
1 year
(56.98)
(17.80)
3 years
(12.99)
23.21
5 years
(85.78)
45.98
Scale: |
High
Low
134.80
54.00
65.00
5.60
47.00
4.00
35.40
17.20
29.40
17.00
42.40
19.00
123.00
25.20
172.40
88.40
189.40
117.60
173.80
126.60
175.40
27.60
51.00
12.00
23.88
5.04
22.45
8.86
32.48
11.50
15.62
4.68
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
Revenue per share
756.45
672.09
625.33
582.83
571.16
589.76
570.89
553.59
546.36
405.52
439.05
410.22
409.42
411.97
448.12
454.50
450.85
Earnings per share
1.17
(29.81)
(69.35)
(11.51)
(12.57)
(8.33)
2.65
5.40
43.44
3.23
0.08
17.98
(7.99)
(8.50)
(1.69)
(9.96)
(11.74)
FCF per share
(2.36)
(18.26)
(4.32)
(11.78)
4.74
0.37
9.82
6.09
2.26
6.39
(4.89)
0.98
(8.96)
5.12
(3.76)
2.93
(2.14)
Dividends per share
0.66
0.42
0.08
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
CAPEX per share
15.72
20.45
12.88
4.40
4.22
5.65
8.61
9.14
11.11
13.08
9.21
4.09
4.63
4.03
4.19
4.08
4.23
Book Value per sh.
71.84
47.28
(28.54)
(38.00)
(50.09)
(58.40)
(55.30)
(45.84)
1.18
11.35
11.76
30.51
22.45
12.67
11.47
1.83
4.93
Comm.Shares outs.
23
36
42
44
44
44
44
46
49
51
52
52
53
53
54
54
54
Avg. annual P/E ratio
91.5
(1.1)
(0.3)
(2.0)
(1.9)
(3.2)
24.6
23.6
3.7
47.6
908.6
1.8
(1.4)
(1.6)
(10.7)
(0.9)
(0.6)
P/E to S&P500
5.3
(0.1)
(0.0)
(0.1)
(0.1)
(0.2)
1.4
1.3
0.2
2.1
38.5
0.1
(0.1)
(0.0)
(0.4)
(0.0)
(0.0)
Avg. annual div. yield
0.6%
1.3%
0.4%
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue (m)
17,508
24,327
26,289
25,669
25,215
26,121
25,392
25,526
26,528
20,770
22,928
21,529
21,640
21,928
24,043
24,568
24,422
Operating margin
2.0%
1.1%
0.2%
0.9%
0.9%
1.0%
2.8%
3.0%
3.3%
3.9%
2.3%
0.6%
0.4%
0.6%
0.2%
0.3%
0.0%
Depreciation (m)
270
472
586
534
506
441
414
404
417
509
568
386
358
328
327
296
290
Net profit (m)
27
(1,079)
(2,915)
(507)
(555)
(369)
118
249
2,109
165
4
943
(422)
(452)
(91)
(538)
(636)
Income tax rate
(92.9)%
(294.0)%
(12.7)%
(5.6)%
(1.8)%
6.0%
(1,382.5)%
0.3%
(394.2)%
74.5%
91.5%
(702.7)%
(13.1)%
(474.9)%
16.8%
0.7%
(0.5)%
Net profit margin
0.2%
(4.4)%
(11.1)%
(2.0)%
(2.2)%
(1.4)%
0.5%
1.0%
8.0%
0.8%
0.0%
4.4%
(2.0)%
(2.1)%
(0.4)%
(2.2)%
(2.6)%
Working capital (m)
1,363
2,124
2,063
2,333
1,991
1,935
1,831
1,778
1,737
1,554
2,060
1,271
1,659
934
992
516
741
Long-term debt (m)
3,084
5,800
5,801
6,319
6,157
6,249
5,996
5,708
5,483
6,967
3,273
3,371
3,479
3,077
5,909
5,345
5,567
Equity (m)
1,663
1,711
(1,200)
(1,674)
(2,211)
(2,587)
(2,459)
(2,114)
57
581
614
1,601
1,187
675
615
99
(8)
ROIC
0.5%
(12.5)%
(48.4)%
0.6%
0.0%
2.7%
172.2%
15.1%
63.9%
2.2%
0.5%
211.0%
(2.6)%
14.2%
1.1%
(6.2)%
(7.8)%
Return on capital
0.2%
(2.4)%
(31.1)%
0.4%
0.0%
1.9%
7.4%
9.7%
9.3%
6.5%
4.1%
16.2%
(1.5)%
1.7%
1.0%
(4.1)%
(5.2)%
Return on equity
1.6%
(63.1)%
243.0%
30.3%
25.1%
14.3%
(4.8)%
(11.8)%
3,696.7%
28.5%
0.7%
58.9%
(35.6)%
(67.0)%
(14.8)%
(543.7)%
7,588.5%
Plowback ratio
43.0%
101.4%
100.1%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Div.&Repurch./FCF
9.2%
- -
- -
- -
- -
- -
(0.4)%
(4.3)%
(22.0)%
(3.5)%
2.7%
(11.2)%
- -
- -
- -
- -
- -
Capital Structure
28 May · 2022 | Q1
All numbers in millions
Total liabilities
$ 8,558
Total assets
$ 8,550
Long-term debt
$ 5,567
Cash and equiv.
$ 56
Goodwill
$ 879
Retained earnings
$ (5,962)
Common stock
54
Enterprise Value
$ 5,874
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
218
161
40
Receivables
1,287
1,462
1,343
Inventory
1,922
1,865
1,959
Other
274
50
(72)
Current assets
3,701
3,595
3,449
Acc. Payable
1,484
1,437
1,571
Debt due
9
523
581
Other
1,274
642
781
Current liabilities
2,766
2,603
2,933
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
2.18%
3.42%
0.08%
Cash flow
(178.51)%
(381.97)%
(191.55)%
Earnings
492.33%
68.69%
2,680.16%
Dividends
- -
- -
- -
Book value
(83.90)%
(40.44)%
89.65%
Insider Trading
Type
Shares
Date
Gilbert Paul D
InKind
2,728
08/17/22
Donigan Heyward R
InKind
37,370
08/12/22
Miramontes Louis
Award
21,505
07/27/22
Mennen Justin L.
Award
49,509
07/27/22
Nayar Arun
Award
21,505
07/27/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2021
6,027
5,982
6,117
5,917
24,043
2022
6,161
6,113
6,229
6,065
24,568
2023
6,015
- -
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
(1.18)
(0.25)
0.08
(0.34)
(1.69)
2022
(0.24)
(1.86)
(0.67)
(7.20)
(9.96)
2023
(2.03)
- -
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Pharmaceutical Retailers
CEO:
Ms. Heyward Donigan
Full-time employees:
53,000
City:
Camp Hill
Address:
30 Hunter Ln
IPO:
May 22, 1981
Website:
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
Recent News